Esperion Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Esperion Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Esperion Therapeutics Inc.
Rating: 2.24908325
Author: Trendlyne DVM scores

about

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

2.90 -0.06 (-2.03%)

26.40% Fall from 52W High

4.3M

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Board Meeting

The next board meeting for Esperion Therapeutics Inc. is on 18 Nov 2025 for the purpose of Jefferies Global Healthcare Conference - London See details

Not Eligible

Expensive Valuation

13.3 / 100

Technically Bullish

76.6 / 100

1Yr Price target upside is 112%

7 analysts

Esperion Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Esperion Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

26.40% Fall from 52W High

SWOT Analysis

Esperion Therapeutics Inc Live Price Chart